New CEO strengthens management
FairJourney Biologics (Porto, PT) has appointed Dr Werner Lanthaler, long-standing Evotec CEO, as Chief Executive Officer. Founder António Parada will focus on innovation strategy on the Supervisory Board.
ADVERTISEMENT
About Maren Kühr
This author has not written his bio yet.
But we are proud to say that Maren Kühr contributed 232 entries already.
Entries by Maren Kühr
New CEO takes over
Contract Research Organization Julius Clinical (NL) appointed Bassem Saleh as its new Chief Executive Officer. His predecessor, Martijn Wallert, will become an advisor to the Executive Board.
New Chief Scientific Officer has started
Tessellate Bio (Naarden, Netherlands; Stevenage, UK) appointed Dr Katie Chapman as Chief Scientific Officer (CSO) at the end of September. She succeeds Dr Jürgen Moll, who will be available to the company in an advisory capacity.
BioFlo® 120 – Performance Meets Value
The Eppendorf BioFlo 120 bioprocess controller offers simplicity and ease of use, without sacrificing capability. No matter if you are in an academic, governmental or industrial research setting, the BioFlo 120 bioprocess controller is an attractive solution to meet your needs – all at an affordable price.
PROTACs and MGDs: The Revolutionary Modalities for Drug Discovery
Stick, Tag, Destroy: The Science of PROTACs and MGDs – For a long time, traditional drug research focused on inhibitors that block the active sites of disease-related proteins. However, around 80% of these proteins remain “undruggable” because they lack clear binding sites.
New Head of Development
Swedish AlzeCure Pharma AB recently appointed Cecilia Wadell as Head of Development. She joins also the management team.
2025 Chikungunya Outbreak: A Global Health Challenge
Chikungunya virus (CHIKV) is a mosquito-borne alphavirus causing fever, severe joint pain, rash, and muscle aches, mainly transmitted by Aedes mosquitoes. The outbreak began on islands in the Indian Ocean and had spread to 119 countries by 2025, including temperate regions such as France. Key control strategies include vector control, surveillance, health system preparedness, and international cooperation. Sino Biological supports research by providing recombinant CHIKV antigens and antibodies, which are useful for vaccines, antiviral drugs, and diagnostics.
Successor found for CEO
Sana Alajmovic has been appointed as the new CEO of the Swedish company Enzymatica AB by the Board of Directors. The current CEO, Claus Egstrand, will become a member of the Board.
Experienced immunologist as CMO
Immunotherapy company Centauri Therapeutics Ltd, based in Alderley Park, Cheshire, UK, has announced the appointment of Dr Debra Barker as Chief Medical Officer (CMO).
New managing director takes over
UK-based contract research, development and manufacturing organisation (CRDMO) Arcinova announced the appointment of Dr Christian Dowdeswell as its new managing director at the beginning of August. Co-founder and CEO Paul Ryan steps down.